The 30% Discount Sitting in Plain Sight: Why Lakers and Celtics Just Re-Priced Every Public Sports Stock

SK Lee — Sports & consumer desk

The NBA Board of Governors approved Mark Walter's majority purchase of the Los Angeles Lakers at a $10 billion valuation in October. The sale closed earlier this month, marking the highest price ever paid for a North American sports franchise. Six months before that, the Boston Celtics traded hands at a $6.1 billion valuation, a number that broke a record that had stood for forty-five days. Two transactions, taken together, have re-set the floor on professional sports team valuations in a way that has not been seen since the broadcast-rights bull run of the late 1990s. The corollary, which the public equity market is only partially absorbing, is that there is exactly one US-listed pure-play equity through which an institutional allocator can express exposure to an NBA franchise. Its stock price implies that the public market disagrees with the private market by about 30%.

The vehicle is Madison Square Garden Sports Corp., ticker MSGS, which owns the New York Knicks and the New York Rangers. As of last week's close, MSGS's enterprise value sat near $9.6 billion. Sportico's most recent independent valuation places the Knicks alone at $9.85 billion and the Rangers at $3.65 billion — a combined private-market estimate of $13.5 billion. The discount is not subtle. The instinct is to read it as a Dolan-family corporate-governance penalty, the historical complaint about the company's controlling shareholder. That read no longer fits the data. The Knicks filed a confidential Form 10 in late May for the separation of the Knicks and the Rangers into distinct listed entities, a structural action that explicitly addresses the conglomerate-discount diagnosis. The market has reacted, but not enough.

The Comparables Did Not Stay Still

The Lakers transaction is the data point that changed every subsequent conversation about NBA franchise values. At $10 billion against fiscal-year revenue of approximately $618 million, the implied revenue multiple is roughly 16 times. The Knicks generated $620 million in fiscal-2026 revenue, narrowly outpacing the Lakers, and operate in the larger Madison Square Garden building with stronger pricing power per seat. Applied directly, a Lakers multiple to Knicks revenue yields a franchise-only valuation of about $9.9 billion — almost exactly the Sportico mark. That arithmetic is not contestable. What is contestable is whether the public market will close the gap to it, and on what timeline.

Guggenheim Securities analyst Curry Baker has been the most explicit on the math. In a June 2 research note, distributed to clients and cited by CNBC, Baker raised his price target on MSGS to $477 from $422, the second of two consecutive increases this spring. The framing was unusually direct for sell-side credit.

"Based on Forbes' valuation, MSG Sports shares should trade between $540 and $570 per share, or a 48% premium to the current share price. There are a number of catalysts to unlock value, including the spin-off of the Knicks and Rangers, and NBA expansion which could yield $13-$20 per share for the Knicks."

— Curry Baker, analyst at Guggenheim Securities, in a June 2, 2026 research note cited by CNBC.

Baker's note arrived during the Knicks' run to the Eastern Conference Finals and was upgraded again after the team's advance, with the price target lifted further to $477. The third-party comparable Baker referenced — Forbes' valuation matrix — places the Rangers at roughly $3.65 billion and the Knicks at $9.75 to $10 billion, consistent with the Sportico number. The point is not whether the precise mark is $13.5 billion or $13.75 billion. The point is that two independent third-party valuation desks, applying different methodologies, have landed within 2% of each other and roughly $4 billion above the current public market value.

The Playoff Cash That Was Not Priced In

The second-order story is operating cash flow. Seaport Research Partners' senior analyst David Joyce, who has covered the stock since the 2020 spin-off from Madison Square Garden Entertainment, raised his price target on MSGS to $435 from $430 on May 27 — and separately quantified the Knicks' 2026 postseason economics in a series of client notes. Joyce's framing has been the cleanest piece of analyst commentary in the file.

"The Knicks' recent playoff run, serendipitously from a corporate finance perspective, will help MSG Sports. Each Finals home game is expected to produce around $20.3 million in revenue, a number likely conservative."

— David Joyce, senior research analyst at Seaport Research Partners, in a May 26, 2026 research note cited by Front Office Sports.

Joyce estimates the full 2026 postseason run generated at least $145 million in gross revenue for the company, with sweeps of the 76ers and Cavaliers reducing the figure by an estimated $29 million versus a non-sweep scenario. That cash flow does not show up in the Sportico franchise-value benchmark, which is a steady-state revenue-multiple construction. It is incremental. Susquehanna's Joseph Stauff captured the read on his end of the sell-side, raising the bank's price target to $429 from $404 on May 28 with a Positive rating maintained. Three analysts at three different firms, all moving in the same direction within a four-week window, against a backdrop of two record private transactions: the signal is consistent.

The Spin Is the Catalyst

The Form 10 filing is the structural piece the discount thesis turns on. By splitting the Knicks and the Rangers into two distinct listed entities, MSG Sports addresses the conglomerate-discount complaint that institutional capital has used to justify the gap. The filing is confidential, which is the standard SEC pre-public process and signals the company is preparing for an actual spin rather than a strategic review. Joyce's read, in an April note distributed before the playoff run, was that the separation "enhances the possibility of raising capital, and makes minority stake sales easier, as there are two distinct teams' business models, which makes for a clearer investment vehicle." The implication, beyond the discount-narrowing math, is that institutional capital — sovereign wealth, private equity, family offices — would have a cleaner mechanism to take minority stakes in a pure-play hockey or basketball franchise at public-market liquidity. That is a meaningful upgrade to the available secondary-market structure for the asset class.

Our View

The trade is long MSGS into the spin completion, with a base case anchored to the Sportico marks. We see three discrete scenarios. At current public marks holding and a modest discount narrowing as the Form 10 progresses, the floor is roughly $416 per share. At consensus team marks and a discount that compresses halfway toward what precedent spin-offs have produced — Liberty Media's Formula One being the cleanest comparable — the target is approximately $480 per share, consistent with Joyce's $435 and Susquehanna's $429. In a bull case where NBA expansion is announced before the spin closes, lifting franchise comparables by another $13-$20 per share per Baker's math, the target moves toward $570 per share, consistent with the Guggenheim Forbes-mark framework.

The risk on the trade is binary: either the Form 10 progresses to public-market separation, or it stalls. The cleanest defensive structure is a long-dated call spread that captures the spin while limiting Dolan-family-related execution-risk downside. We would also pair the position with a short in Liberty Media Formula One Series C, which currently trades at a tighter discount to its underlying asset value and is therefore the structurally weaker leg in a pair trade against MSGS.

The Lakers sold for $10 billion. The Celtics sold for $6.1 billion. The Knicks plus the Rangers, on every credible third-party mark, are worth $13.5 billion. The public market values them at $9.6 billion. That is the trade. The Form 10 is the catalyst. The August earnings cycle is the read.

This commentary is prepared for institutional and accredited audiences and does not constitute investment advice. Positions and views are those of Solomon Grey Capital and may change without notice.